Design Therapeutics, Inc. - Common Stock (DSGN)

CUSIP: 25056L103

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
-1,016,712
Put/Call ratio
100%
SEC-reported price per share
$4.03
Indexed holders
88
Value change
-$3,107,582
Number of buys
36
Open additional details 1 more signal available
Number of sells
50
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
62,618,885

Security key

25056L103

Report period

Q1 2024

Indexed institutions

88

Top holders

10

Ownership snapshot

Top reported holders of DSGN - Design Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SR One Capital Fund I Agg...
Disclosed value leader
SR ONE CAPITAL MANAGEMENT...
Comparable rows
0/15
Latest evidence
31 Dec 2023
3/4/5 13F Highest disclosed value: $17,295,161 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

SR ONE CAPITAL MANAGEMENT, LP has the largest disclosed position value at $17.3M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SR ONE CAPITAL MANAGEMENT, LP's linked filing trail.
Disclosed position value Top 5
SR One Capital Fund I Aggregator LP $15.32M
SR ONE CAPITAL MANAGEMENT, LP $17.3M
Logos Global Management LP $13.34M
BlackRock Finance, Inc. $6.31M
CITADEL ADVISORS LLC $4.86M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SR One Capital Fund I Aggregator LP
3/4/5
10%+ Owner
—
denominator unverified
$15,317,639
6,526,476 shares
— 16 Dec 2022
Aseem Z. Ansari
3/4/5
10%+ Owner
—
denominator unverified
—
100,000 shares
— 01 Dec 2023
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
13F
—
denominator unverified
$17,295,161
6,526,476 shares
— 31 Dec 2023
Logos Global Management LP
13F
Company
13F
—
denominator unverified
$13,336,128
5,032,501 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$6,307,642
2,380,242 shares
— 31 Dec 2023
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$4,855,473
1,832,254 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
88
Shares
30,700,544
Indexed holders
88
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 indexed holders
87
Q1 2024 indexed holders
88
Indexed holder difference
1
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .